[2020-2027] Cardiac Biomarker Market is Poised for Steady Growth at CAGR of 18.9%
Pune, Maharashtra, India, February 18 2021 (Wiredrelease) Allied Analytics –:The global Cardiac Biomarker Market would generate the revenue at CAGR of 18.9%. Cardiac Troponins (T, I) would continue to dominate the market throughout the forecast period due to high sensitivity and specificity. Continuous focus on pipeline research and developments from leading players and increased patient awareness across untapped region such as India, China are largely driving the growth of cardiac biomarkers market.
Request Sample Report at https://www.alliedmarketresearch.com/request-sample/309
The growing application of cardiac biomarkers as point of care (POC) testing facilitate quick results in chronic conditions, thus drives the market growth. However, specificity and sensitivity related concerns of single measurement cardiac biomarkers, premium pricing and certain government regulations would hinder the market growth. Also, the overall market growth would bank on novel progress made in cardiac treatments using multi-assay biomarkers. The lifesaving benefits of these multi-assay biomarkers would foster the revenue generation process as well as market penetration of novel cardiac biomarkers in future.
North America would continue to lead the market owing to high awareness, and favorable healthcare reimbursement policies. In addition, Asia Pacific would emerge as one of the most lucrative regions and would closely follow Europe in terms of revenue. Prime factor fuelling the growth of Asia Pacific region include, presence of large number of undiagnosed cardiac patient, rapid urbanization, rising disposable income, and growing awareness about cardiac disease management programs i.e. quick cardiac checkup (QCC).
Key findings of the study:
• Troponin segment is projected as a leading market segment throughout the forecast period
• Revenue of myocardial infarction application segment is expected to grow almost three fold by 2020
• Laboratory location of testing market segment still dominates the global market
• Point of care location of testing segment is projected to grow at a CAGR of 22% during the forecast period
• Countries like India and China holds prominent potential owing to higher count of undiagnosed cardiac patients
The principal strategy adopted by the leading players in the market is the product launch. The key companies profiled in the report are Abbott laboratories, Alere Inc., Siemens Healthcare, Roche Diagnostics Corporation, Beckman Coulter, Becton, Dickinson and Company, Thermo Fisher Scientific, BioMerieux, Bio-Rad Laboratories and Randox laboratories.
Access AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) at:
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at firstname.lastname@example.org.